Skip to Main Content Skip to Site Map Skip to Accessibility Statement

AZTEC

Trial Acronym AZTEC
Trial Title AZacitidine Treatment Effect on Hypertrophic Cardiomyopathy
Clinical Area Symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM)
Trial Status Set Up
Chief Investigator (CI) Dr Lana Dixon, Belfast Health & Social Care Trust
Sponsor Belfast Health and Social Care Trust
Funder British Heart Foundation, Innovate UK and The Heart Trust Fund

For any queries regarding this trial please contact the study email (AZTEC@nictu.hscni.net) or call the NICTU (028 9615 1447).

 

Quick Links

Services